Clinical Research Coordinator with over 15 years of experience in pulmonary and allergy clinical trials. Specialized in FDA-regulated, GCP-compliant research operations, with a proven track record of managing over 50 trials, including asthma, COPD, chronic cough, and interstitial lung disease. Highly proficient in patient recruitment, IRB submissions, study visit execution, and sponsor communication. Recognized for precision, collaboration, and adaptability in complex, fast-paced clinical research environments.
· Coordinated over 25 Phase II–III clinical trials.
· Key trials included Tezepelumab, QAW039, Benralizumab, Dupilumab, Reslizumab, and multiple ICS/LABA therapies.
· Oversaw patient enrollment, PFT Master scope, AE documentation, sample handling, and sponsor communication.
· Managed IRB submissions and monitoring visits for global and regional studies.